DrugPatentWatch Database Preview
Drugs in Development Information for Omecamtiv Mecarbil
» See Plans and Pricing
What is the development status for investigational drug Omecamtiv Mecarbil?
Omecamtiv Mecarbil is an investigational drug.
There have been 10 clinical trials for Omecamtiv Mecarbil.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 7th 2018.
The most common disease conditions in clinical trials are Heart Failure, Ventricular Dysfunction, Left, and [disabled in preview]. The leading clinical trial sponsors are Amgen, Cytokinetics, and Servier.
There are seventeen US patents protecting this investigational drug and one hundred and twenty-three international patents.
Summary for Omecamtiv Mecarbil
| US Patents | 17 |
| International Patents | 123 |
| US Patent Applications | 24 |
| WIPO Patent Applications | 11 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-12-07) |
| Vendors | 59 |
Recent Clinical Trials for Omecamtiv Mecarbil
| Title | Sponsor | Phase |
|---|---|---|
| Omecamtiv Mecarbil Post-trial Access Study | Amgen | Phase 3 |
| Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Subjects | Amgen | Phase 1 |
| Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure | Cytokinetics | Phase 3 |
Clinical Trial Summary for Omecamtiv Mecarbil
Top disease conditions for Omecamtiv Mecarbil
Top clinical trial sponsors for Omecamtiv Mecarbil
US Patents for Omecamtiv Mecarbil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Omecamtiv Mecarbil | Start Trial | Compounds, compositions and methods | Cytokinetics, Incorporated (South San Francisco, CA) | Start Trial |
| Omecamtiv Mecarbil | Start Trial | Compounds, compositions and methods | CYTOKINETICS, INC. (South San Francisco, CA) | Start Trial |
| Omecamtiv Mecarbil | Start Trial | Heterocyclic compounds and their uses | AMGEN INC. (Thousand Oaks, CA) | Start Trial |
| Omecamtiv Mecarbil | Start Trial | Compounds, compositions and methods | Cytokinetics, Inc. (South San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Omecamtiv Mecarbil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Omecamtiv Mecarbil | Argentina | 053405 | 2024-06-17 | Start Trial |
| Omecamtiv Mecarbil | Australia | 2005264988 | 2024-06-17 | Start Trial |
| Omecamtiv Mecarbil | Brazil | PI0512193 | 2024-06-17 | Start Trial |
| Omecamtiv Mecarbil | Canada | 2570999 | 2024-06-17 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
